Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Gene Therapy for Lung Cancer

Volumen 21, Edición 1-2, 2016, pp. 115-124
DOI: 10.1615/CritRevOncog.2016016084
Get accessGet access

SINOPSIS

Gene therapy was originally conceived to treat monogenic diseases. The replacement of a defective gene with a functional gene can theoretically cure the disease. In cancer, multiple genetic defects are present and the molecular profile changes during the course of the disease, making the replacement of all defective genes impossible. To overcome these difficulties, various gene therapy strategies have been adopted, including immune stimulation, transfer of suicide genes, inhibition of driver oncogenes, replacement of tumor-suppressor genes that could mediate apoptosis or anti-angiogenesis, and transfer of genes that enhance conventional treatments such as radiotherapy and chemotherapy. Some of these strategies have been tested successfully in non-small-cell lung cancer patients and the results of laboratory studies and clinical trials are reviewed herein.

PALABRAS CLAVE: lung cancer, gene therapy
CITADO POR
  1. Lee Ah Young, Cho Myung-Haing, Kim Sanghwa, Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy, Expert Opinion on Drug Delivery, 16, 7, 2019. Crossref

  2. Santos Renata Virgínia Cavalcanti, de Sena Wanessa Layssa Batista, dos Santos Flaviana Alves, da Silva Filho Antônio Felix, da Rocha Pitta Marina Galdino, da Rocha Pitta Maira Galdino, de Melo Rego Moacyr Barreto, Pereira Michelly Cristiny, Potential Therapeutic Agents Against Par-4 Target for Cancer Treatment: Where Are We Going?, Current Drug Targets, 20, 6, 2019. Crossref

  3. Abdelaziz Hadeer M., Freag May S., Elzoghby Ahmed O., Solid Lipid Nanoparticle-Based Drug Delivery for Lung Cancer, in Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer, 2019. Crossref

  4. DeMaio Andrew, Sterman Daniel, Bronchoscopic intratumoural therapies for non-small cell lung cancer, European Respiratory Review, 29, 156, 2020. Crossref

  5. Qi Qian‑Ming , Xue Yin‑Cun , Lv Jian , Sun Di , Du Jian‑Xin , Cai Sheng‑Qiang , Li Yun‑He , Gu Tian‑Cun , Wang Mu‑Bing , Ginkgolic acids induce HepG2 cell death via a combination of apoptosis, autophagy and the mitochondrial pathway, Oncology Letters, 2018. Crossref

  6. Holt Gregory E, Daftarian Pirouz, Non-small-cell lung cancer homing peptide-labeled dendrimers selectively transfect lung cancer cells, Immunotherapy, 10, 16, 2018. Crossref

  7. Niu Zhigao, Zhang Wenping, Shi Jialun, Li Xiangdong, Wu Hanlei, Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation, Journal of Cardiothoracic Surgery, 16, 1, 2021. Crossref

  8. Bisserier Malik, Sun Xiao-Qing, Fazal Shahood, Turnbull Irene C., Bonnet Sébastien, Hadri Lahouaria, Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases, Cells, 11, 6, 2022. Crossref

  9. Chaudhary Swati, Singh Amit, Kumar Pankaj, Kaushik Mahima, Strategic targeting of non‐small‐cell lung cancer utilizing genetic material‐based delivery platforms of nanotechnology, Journal of Biochemical and Molecular Toxicology, 35, 7, 2021. Crossref

  10. Singh Vijayata, Khan Nusrat, Jayandharan Giridhara R., Vector engineering, strategies and targets in cancer gene therapy, Cancer Gene Therapy, 29, 5, 2022. Crossref

  11. Wang Jian, Mo Jianming, Xie Yuancai, Wang Chunguang, Ultrasound microbubbles-mediated miR-216b affects MALAT1-miRNA axis in non-small cell lung cancer cells, Tissue and Cell, 74, 2022. Crossref

  12. Ichikawa Misa, Muramatsu Naomi, Matsunaga Wataru, Ishikawa Takahiro, Okuda Tomoyuki, Okamoto Hirokazu, Gotoh Akinobu, Effects of inhalable gene transfection as a novel gene therapy for non-small cell lung cancer and malignant pleural mesothelioma, Scientific Reports, 12, 1, 2022. Crossref

  13. Gao Fangfang, Mu Xiaoqian, Wu Huijuan, Chen Lijuan, Liu Jie, Zhao Yanqiu, Calreticulin (CALR)-induced activation of NF-ĸB signaling pathway boosts lung cancer cell proliferation, Bioengineered, 13, 3, 2022. Crossref

  14. Artzy-Schnirman Arbel, Arber Raviv Sivan, Doppelt Flikshtain Ofri, Shklover Jeny, Korin Netanel, Gross Adi, Mizrahi Boaz, Schroeder Avi, Sznitman Josué, Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics, Advanced Drug Delivery Reviews, 176, 2021. Crossref

  15. Lin Xin-Rui, Zhou Xin-Liang, Feng Qiang, Pan Xin-Yan, Song Shu-Ling, Fang Hong, Lei Jin, Yang Ju-Lun, CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer, Journal of Cancer Research and Clinical Oncology, 145, 5, 2019. Crossref

  16. Sivarajah Shanmugappiriya, Emerick Kevin, Kaufman Howard L., What Surgeons Need to Know About Gene Therapy for Cancer, Advances in Surgery, 56, 1, 2022. Crossref

  17. Chen Shipeng, Guan Lian, Zhao Xu, Yang Jing, Chen Longqing, Guo Mengmeng, Zhao Juanjuan, Chen Chao, Zhou Ya, Han Yong, Xu Lin, Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells, Journal of Zhejiang University-SCIENCE B, 23, 11, 2022. Crossref

  18. Kushiya Hiroki, Hiraoka Kei, Suzuki Tomohiro, Inoko Kazuho, Inagaki Akihito, Niwa Hiroki, Sasaki Katsunori, Nakamura Toru, Tsuchikawa Takahiro, Shichinohe Toshiaki, Jolly Douglas J., Kasahara Noriyuki, Hirano Satoshi, Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer, Cancers, 14, 23, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain